Bladder-Cancer-banner-NEW v2
 

Please feel free to forward to your colleagues and share the news of our journal

***

NEW ISSUE

Dear Colleague,

We are delighted to announce the publication of Volume 8, Issue 1 of Bladder Cancer (BLC). This issue hosts an outstanding selection of content, including an article commentary on urine bladder cancer markers, a systematic review, and six research articles. From the editors of the regular journal sections, there are also new Challenging Case, Clinical Trials Corner, and Paper Alert contributions. All content is freely accessible and can be viewed via the links below. We also share news of the journal supporting IOS Press' actions relating to the UN sustainable development goals (SDGs).

BLC-purple-divider

Call for Papers

As a member of our research community, we would like to invite you to contribute your own research articles to Bladder Cancer, which offers contributing authors many benefits:

• First class Editorial Board
• Rigorous peer review and speedy manuscript processing
• Rapid online publication (pre-press)

Submit your manuscript online via Editorial Manager
View detailed Instructions to Authors
Aims and Scope

We look forward to working with you.

Best wishes,

Editors-in-Chief

Seth P. Lerner, MD
Scott Department of Urology
Baylor College of Medicine
Houston, Texas, USA
Email: blc@iospress.com

Dan Theodorescu, MD, PhD
Samuel Oschin Comprehensive Cancer Institute
Cedars-Sinai Medical Center
Los Angeles, California, USA
Email: blc@iospress.com

BLC-purple-divider

All content is currently freely available online to all readers

Article Commentary
Sensitivity and Specificity in Urine Bladder Cancer Markers – Is it that Simple?Openly Available
Roghmann, Florian | Goebell, Peter J. | Dyrskjøt, Lars | van Rhijn, Bas W.G. | Käfferlein, Heiko U. | Hakenberg, Oliver | Stenzl, Arnulf | Burger, Maximilian | Pesch, Beate | Benderska-Söder, Natalya | et al.

Systematic Review
Systematic Review and Meta-Analysis of Cisplatin Based Neoadjuvant Chemotherapy in Muscle Invasive Bladder CancerOpenly Available
Benkhadra, Raed | Nayfeh, Tarek | Patibandla, Sai Krishna | Peterson, Chelsea | Prokop, Larry | Alhalabi, Omar | Murad, M. Hassan | Mao, Shifeng S.

RESEARCH ARTICLES
Identification of a Novel Ferroptosis-Related Gene Signature for Prediction of Prognosis in Bladder Urothelial CarcinomaOpen Access
Shi, Xiaokai | Zhou, Xiao | Zhang, Lei | Yue, Chuang | Gao, Shenglin | Cheng, Jiasheng | Zuo, Li | Zhang, Lifeng

Accuracy of Inchworm Sign on Diffusion-Weighted MRI in Differentiating Muscle-Invasive Bladder CancerOpenly Available
Kazan, Huseyin Ozgur | Culpan, Meftun | Gunduz, Nesrin | Keser, Ferhat | Iplikci, Ayberk | Atis, Ramazan Gokhan | Yildirim, Asif

Qualitative Analysis of Pain in Patients With Locally Advanced or Metastatic Urothelial CarcinomaOpenly Available
Martin, Susan | Shah, Sonali N. | Hepp, Zsolt | Harris, Nimanee | Morgans, Alicia K.

Quality of Life and Health State Utilities in Bladder CancerOpenly Available
Smith, Angela B. | McCabe, Sean | Deal, Allison M. | Guo, Amy | Gessner, Kathryn H. | Lipman, Robert | Chisolm, Stephanie | Ahlschlager, Lauren | Gore, John L.

Implications for Efficacy and Safety of Total Dose and Dose-Intensity of Neoadjuvant Gemcitabine-Cisplatin in Muscle-Invasive Bladder Cancer: Three-Week Versus Four-Week RegimenOpen Access
Holmsten, Karin | Omland, Lise Høj | Als, Anne Birgitte | Agerbæk, Mads | Dohn, Line Hammer | Lindberg, Henriette | Jensen, Niels Viggo | Carus, Andreas | Moe, Mette | et al.

Association between Patient-Reported Outcomes and Survival in Patients with Advanced Urothelial Carcinoma Treated with AtezolizumabOpenly Available
Tan, Eugene | Abuhelwa, Ahmad Y. | Badaoui, Sarah | Modi, Natansh D. | Wiese, Michael D. | McKinnon, Ross A. | Sorich, Michael J. | Hopkins, Ashley M.

Other Content
Challenging Cases in Urothelial Cancer: Case 23Openly Available
Soloway, Mark S. | Abrahams, Neil A.

Clinical Trials Corner Issue 8(1)Openly Available
Agarwal, Piyush K. | Sternberg, Cora N.

Paper Alert: Antibiotics and BCGOpenly Available
Messing, Edward M.

BLC-purple-divider

Upcoming Webinar

BCAN offers regular patient insight webinars, bringing nationally recognized bladder cancer experts directly to patients and families to address important topics related to bladder cancer diagnosis, treatment, research and quality of life. Highlighted below is the upcoming online webinar that takes place in April.

Understanding Upper Tract Urothelial Carcinoma (UTUC) | Apr 5, 17:00 ET
This webinar will include urologist Surena Matin, medical oncologist Matthew Campbell, and urologist Kate Murray discussing UTUC and explaining the similarities and differences from other forms of bladder cancer in its diagnosis and treatment options. Register now to:

▪ Increase your understanding of who is at risk for developing UTUC and how it is discovered
▪ Learn how UTUC is evaluated
▪ Understand how UTUC is treated
Increase your understanding of who is at risk for developing UTUC and how it is discovered
Learn how UTUC is evaluated
Understand how UTUC is treated

Visit Bladder Cancer Expert Videos for previous webinars, programs, and treatment talks.

BLC-purple-divider

Most Viewed BLC Articles in Q1 2022

Listing the top viewed journal papers in the IOS Press Content Library

In the World of Bladder Tumors: Size Does Matter (Research Article in Vol.6, Iss.2, 2020) – Open Access
Loloi, Justin | Allen, Jordan L. | Schilling, Amber | Hollenbeak, Christopher | Merrill, Suzanne B. | Kaag, Matthew G. | Raman, Jay D.

Histologic Variants of Urothelial Carcinoma: Morphology, Molecular Features and Clinical Implications (Review Article in Vol.6, Iss.2, 2020) – Open Access
Alderson, Meera | Grivas, Petros | Milowsky, Matthew I. | Wobker, Sara E.

Cisplatin Ineligibility for Patients With Metastatic Urothelial Carcinoma: A Survey of Clinical Practice Perspectives Among US Oncologists (Research Article in Vol.5, Iss.4, 2019) – Open Access
Galsky, Matthew D. | Ma, Esprit | Shah-Manek, Bijal | Mills, Rosalina | Ha, Long | Krebsbach, Craig | Blouin, Eric | Tayama, Darren | Ogale, Sarika

Systematic Review: Targeting HER2 in Bladder Cancer (Review Article in Vol.5, Iss.1, 2019) – Open Access
Koshkin, Vadim S. | O’Donnell, Peter | Yu, Evan Y. | Grivas, Petros

CIS of the Bladder: Significance and Implications for Therapy (Review Article in Vol.5, Iss.3, 2019) – Open Access
Mirabal, Jorge Rivera | Taylor, John A. | Lerner, Seth P.

BLC-purple-divider

BLC Journal News

BLC news square

Supporting the IOS Press Diversity and Inclusion Statement

IOS Press is a signatory of the UN SDG Publishers Compact and is taking actions relating to specific sustainable development goals (SDGs). This includes working with journal editors to share recommendations in relation to SDG 5 (gender equality) and SDG 10 (reducing inequalities) in terms of diversity. We are pleased to announce that our journal supports the IOS Press Diversity and Inclusion Statement and is committed to take action to improve geographical and gender equality for the journal. Any updates will be shared on the IOS Press journal page in due course.

BLC-purple-divider

Please Share the BLC Newsletter With Your Colleagues

Help Spread the News of BLC!

If you know of any colleagues or fellow researchers who are not yet signed up to receive the newsletter, we invite you to share this mailing with them. Click on the visual or access the sign-up link here.

BLC has an active social media presence. If you are not yet interacting with the journal on social media, why not take the time today to follow us on Twitter?

Be part of the discussion!

BLC-purple-divider
***

You are receiving this mailing as you are signed up to receive news from BLC.
You can unsubscibe or alter your preferences at any time by clicking the links below
.

 
 
Powered by Mad Mimi®A GoDaddy® company